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Abstract Mitochondria are known to be a major
source and target of oxidative stress. Oxidative stress
increases during aging and is suggested to underlie in
part the aging process. We have previously docu-
mented an increase in endogenous caspase-2 (casp2)
activity in hepatocytes obtained from old (28 months)
vs. young mice (5 months). More recently, we have
shown that casp2 is activated by oxidative stress and is
critical for mitochondrial oxidative stress-induced
apoptosis. Since casp2 appears integral to mitochon-
drial oxidative stress-induced apoptosis, in this study
we determined whether loss of casp2 altered the
production of mitochondrial reactive oxygen radicals
(mROS) as a function of age in intact living hepato-
cytes. To stimulate mitochondrial metabolic activity,
we added a mixture of pyruvate and glutamate to
hepatocytes while continuously monitoring endoge-
nous mROS production in the presence or absence of
rotenone and/or antimycin A. Our data demonstrate
that mROS production and neutralization are compro-
mised in hepatocytes of old mice. Interestingly, casp2
deficient hepatocytes from middle age mice
(12 months) had similar mROS neutralization kinetics
to those of hepatocytes from old WT mice. Rotenone
had no effect on mROS metabolism, whereas antimy-
cin A significantly altered mROS production and
metabolism in an age-dependent fashion. Our results
indicate that: (1) hepatocytes from young and old mice
respond differently to dysfunction of the mitochon-
drial electron transport chain; (2) age-dependent
alterations in mROS metabolism are likely regulated
by complex III; and (3) absence of casp2 accelerates
age-dependent changes in terms of pyruvate/gluta-
mate-induced mROS metabolism.
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Introduction
With aging, there is a general decrease in liver size and
thus in hepatocyte number (Thomas et al. 2002). Rat
hepatocytes demonstrate reductions in both prolifera-
tive capacity and resistance to oxidative stress as a
function of aging (Ikeyama et al. 2003). Previous studies
in aged liver have reported oxidant stress-induced
damage to mitochondria macromolecules (Rabek et al.
2003, Lopez-Torres et al. 2002, Bakala et al. 2003).
We have previously reported that liver of old mice
have increased cysteine oxidation (Zhang et al. 2007)
that parallels age-related dysfunction of mitochondria
and is thought to be a major determinant of this decline
in cell function, since these organelles are both the
main sources of reactive oxygen species (ROS) and
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targets for their damaging effects (Lanza and Nair
2012). Age-associated damage to mitochondria is a
consequence of increased oxidant production (Cala-
brese et al. 2011), probably due to changes in the
activity of key components of the respiratory chain
(Ralph et al. 2011). Recent studies indicate that
mitochondria are one of the major sources of cellular
ROS and, in turn, are the most adversely affected
organelles during aging (Lee and Wei 2012).
Liver shows a progressive increase with age in the
activity of caspases that mediate apoptosis induced
through the mitochondrial pathway (Zhang et al.
2002). In fact, the extent of liver apoptosis is higher in
old mice that have reduced levels of MnSOD than in
age-matched WT mice (Kokoszka et al. 2001). In
addition, hepatocytes isolated from old rats are more
sensitive to oxidant-induced cell death than hepato-
cytes isolated from young rats (Zhang et al. 2002).
Casp2 is a member of a family of cysteine proteases
that are key regulatory components in apoptosis (Bou-
chier-Hayes and Green 2012). Casp2 has been found to
be expressed in many cell types (Krumschnabel et al.
2009), and localized in several subcellular compart-
ments (Susin et al. 1999, Mancini et al. 2000, Guo et al.
2002, Troy and Shelanski 2003). We have recently
shown that casp2 is critical for mitochondrial oxidative
stress-induced apoptosis because its absence protects
cells treated with mitochondrial complex I and III
inhibitors, such as rotenone and antimycin A from
apoptosis (Lopez-Cruzan et al. 2005, Tiwari et al. 2011).
We also have shown that mitochondria contain oxida-
tive stress activatable casp2 (Lopez-Cruzan et al. 2005).
Interestingly, we found increased casp2 activity in aged
rat livers that is associated with age-dependent increases
in oxidative stress (Zhang et al. 2002). Therefore, casp2
may play a role in oxidative stress-induced apoptosis in
aged animals. However, little is known about the
function of casp2 in vivo. We have recently found that
old male Casp2-/- mice exhibit several traits com-
monly observed in premature aging animals, including a
10 % shortened maximum lifespan and severe age-
related osteoporosis (Zhang et al. 2007).
Casp2 has been placed as a central player in the
mitochondrial pathway of apoptosis (Robertson et al.
2002; Braga et al. 2008; Madesh et al. 2009; Bouchier-
Hayes and Green 2012; Jiang et al. 2012). Small
interfering RNA (siRNA) to casp2 inhibited expres-
sion of casp2, prevented cytochrome c and Smac
release from mitochondria and apoptosis after
treatment with cytotoxic agents that can potentially
generate ROS (e.g. etoposide, cisplatin and UV
irradiation) (Lassus et al. 2002).
In this study, we determined whether loss of casp2
impacted mROS production and metabolism during
aging in mouse hepatocytes as a model. Our data
indicate that loss of casp2 accelerates age-dependent
alterations in mROS production and metabolism,
likely through complex III and may in part explain
the accelerated aging phenotype that we observe in
casp2 null mice (Zhang et al. 2007).
Materials and methods
Reagents
Rotenone, antimycin A, Pyruvate, Collagenase Type
IV, and Glutamate were purchased from Sigma.
MitoSOX (510 nm excitation, 580 nm emission) was
obtained from Molecular Probes.
Mice
Casp2-/- mice were a gift from Dr. Carol Troy. Only
male mice were used in these studies. In the present
studies, we used mice at ages 5, 12 and 28 months of
age. This represents for 5 month old WT mice 12 % of
their maximum lifespan, 73.9 % for 28 month old
WT, and 28.7 % and 31.7 % for 12 month old WT and
Casp2-/- respectively.
Hepatocyte isolation
Hepatocytes were isolated using the method of Herman
et al. 1988, from 5 and 28 month old male WT mice or
12 month old Casp2-/- and WT mice. In brief,
animals were anesthetized and their livers perfused
with basic medium solution containing 0.5 mM EGTA
(115 mM NaCl, 5 mM KCl, 1 mM KH2PO4, 25 mM
Na-HEPES) followed by a collagenase solution con-
taining 1 mM CaCl2. After washing and dispersing the
cells, they were counted. An average of 25 million
hepatocytes per liver was obtained.
Mitochondrial production of ROS
Animals were handled according to the University’s
Institutional Animal Care and Use Committee approved
regulations, protocols, and standards. Hepatocytes were
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isolated from 5 to 28 month old WT mice or 12 month
old Casp2-/- and WT mice. After hepatocytes were
isolated as explained above, cells were washed and
dispersed, and counted. After determining cell viability
(85–95 %), hepatocytes were seeded at 250,000 cells per
well in two-well glass chambers and incubated for a
minimum of 9 h to a maximum of 20 h. Generation of
ROS over time was monitored with MitoSOX as
previously described (Ramanujan and Herman 2007).
Cells were washed once and incubated with 2.5 lM
MitoSOX during 10 min at 37 C in the dark and diluted
with HBSS containing Ca2? and Mg2?, followed by two
washes with buffer. HEPES was added at a final
concentration of 30 mM to avoid fluctuations in pH
while the measurements were accomplished. Readings
were performed in a confocal inverted LSM510 Zeiss
microscope using a 609 oil immersion objective and an
argon laser to detect MitoSOX through a 514 nm
excitation/560 nm emission channel. Recordings were
performed in live cells using 70 scans in a time period of
13–15 min. After the 20th scan, a mixture of pyruvate
and glutamate (PG) was added to the chamber to a final
concentration of 5 mM. In some experiments, hepato-
cytes were treated with 20 lM of rotenone, 20 lM
antimycin A or 20 lM of a mixture of both and cells were
incubated for 30 min. Cells were then washed with PBS
and prepared as described above for mROS measure-
ments. Three regions of interest were independently
scanned and each experiment was repeated from six to
nine times. Data was normalized for basal intensity by
first dividing the intensity obtained at each time point by
the initial intensity. Then, the best fit curve in nonlinear
regression was found and used to normalize each time
point. Analysis was performed with GraphPad Prism
software, version 5. For specific time points, one-way
ANOVA was used to analyze statistical differences,
followed by Bonferroni posttests to discern what groups
where significant. At least three animals were used for
each sampling group. For the untreated experiments,
results were pooled together and statistically analyzed.
The results provided for hepatocytes treated with mito-
chondrial complex inhibitors are presented as individual
graphs to highlight the similar response pattern.
Results
In the present study, we have examined the generation
of mROS as a function of age in hepatocytes isolated
from WT mice and also the impact of casp2 deficiency
in the generation of mROS. Liver hepatocytes were
selected as a model to study the action that absence of
casp2 exerts in mitochondria since these cells are
enriched with this organelle. We initially investigated
the endogenous generation of mROS in hepatocytes
isolated from young and old WT mice upon feeding
the mitochondrial electron transport chain with PG
(Fig. 1a) and the mitochondrial probe MitoSOX.
MitoSOX is known to selectively label mitochondrial
superoxide radicals. All cells considered in these
experiments showed distinct mitochondrial labeling.
Hepatocytes are abundant in mitochondria due to their
high metabolic activity and the basal ROS levels in
hepatocytes were almost equal in both young and aged
hepatocytes. There was no statistical difference
observed between the dye uptake of young and aged
hepatocytes. MitoSOX is reported to have a high
response time so that in the time scales of measure-
ment, it is ensured that the probe senses the free
radicals in real time. Mitochondria from younger WT
hepatocytes tended to produce slightly more mROS
than older WT hepatocytes at the peak of PG
stimulation (Figs. 1a, 2a). However, as expected,
younger hepatocyte mROS neutralization kinetics
was more efficient compared to the mROS kinetics
of hepatocytes from older mice. Since we are inter-
ested in analyzing the role that casp2 plays in
mitochondrial oxidative stress induced apoptosis, we
next assayed the response of PG-induced mROS
metabolism (we defined the metabolism of mROS as
the amount of decrease in the MitoSOX signal at
t = 200 s to t = 800 s) in Casp2-/- hepatocytes
isolated from middle age mice and compared it to
the response of hepatocytes obtained from age-
matched WT mice (Fig. 1b). We chose middle age
animals because in parallel with the present studies,
our laboratory has demonstrated that liver from middle
age Casp2-/- mice exhibit a general increase in
protein oxidation identical to that seen in old WT
mouse livers (Zhang et al. 2007). Hepatocytes from
middle age Casp2-/- mice demonstrated lower max-
imal mROS production and decreased metabolism of
mROS compared to hepatocytes from age-matched
WT mice. In fact, the middle age Casp2-/- mROS
levels never reached below the baseline for the
duration of the measurement, while middle age WT
mROS level quickly went below the baseline. It is
important to note that the hepatocytes isolated and
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used for these experiments (Fig. 1c) were free from
contamination with other cell types as seen by the
presence of binucleate cells and the richness of
mitochondria within each cell. This technique has
been employed in our laboratory for more than 20
years (Herman et al. 1988).
The graphs in Fig. 2 demonstrate differences in
mROS intensity at baseline (i.e. before PG was added,
t = 200 s), peak mROS levels after PG stimulation
(t = 250 s) and mROS decay at 800 s after the
recording began. Changes in baseline intensity were
relatively small for all ages of hepatocytes and there
were no statistically significant differences in baseline
mROS levels (t = 200 s; Fig. 2a; note minute scale).
However, peak mROS intensities obtained after PG
stimulation did show substantial and statistically
significant differences between ages and casp2 content
(Fig. 2b). Hepatocytes from middle age WT mice
showed the greatest increase in mROS production. In
comparison, hepatocytes obtained from old WT mice
showed statistically significant lower PG stimulated
increases in mROS levels. mROS production in
hepatocytes obtained from young WT mice did not
show a significant difference compared to those from
WT middle age mice. Interestingly, mROS levels seen
in old hepatocytes following PG stimulation were
identical to those seen in PG-stimulated hepatocytes
obtained from middle aged Casp2-/- mice. In addi-
tion to peak mROS production, we also examined how
well hepatocytes metabolized PG-induced mROS as a
function of age and in the absence of casp2 (Fig. 2c).
We observed an age-dependent impact on the ability
of hepatocytes to metabolize mROS. Young hepato-
cytes were the most efficient while the least effective
were hepatocytes from old WT mice. Interestingly, the
most compromised of all hepatocytes in terms of
mROS metabolism were those obtained from middle-
aged Casp2 null mice.
Next we sought to dissect the genesis of the changes
in mROS that we observed. Therefore, we investigated
mROS metabolism in hepatocytes from young and old
WT mice following inhibition of complex I and III by
rotenone (Fig. 3a, b, c) or antimycin A (Fig. 4a, b, c)
respectively, in a time dependent manner. We used the
same concentrations of rotenone and antimycin A, and
incubation times to pre-treat hepatocytes, and then
created a burst of mitochondrial respiration by adding
a mixture of PG while scanning images of live cells to
detect mROS previously stained with MitoSox Red.
Figures 3 and 4 show graphs of three independent
experiments that we present separated to avoid
masking the results by the large standard error that









































Fig. 1 Age and casp2-dependent differences in mROS metabo-
lism. Hepatocytes were isolated from 5 (young), 12 (middle age) and
28 (old) month old WT and 12 month Casp2-/- mice by perfusing
their livers with a buffer solution containing EGTA, followed by
collagenase treatment. Dispersed hepatocytes were seeded in glass-
bottom well chambers and stained with MitoSOX. Cells were then
placed in a confocal microscope and the production of mROS was
monitored over time after the addition of a mixture of 5 mM
pyruvate and glutamate. Recordings were performed for 13–15 min.
a Mitochondrial ROS production over time in 5 and 28 month old
WT mouse hepatocytes. b Mitochondrial ROS production over time
in 12 months old Casp2-/- and WT mouse hepatocytes. Data was
normalized for basal intensity. Error bars = ± SEM. c Represen-
tative image of isolated hepatocytes labeled with mitochondrial ROS
probe MitoSOX. No images analyzed or visually tested showed any
contamination with other type of cells
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they generate, but to show the trend in treatments of
rotenone and antimycin A. mROS kinetics of rotenone
treated hepatocytes failed to demonstrate any differ-
ences in terms of the maximum burst of mROS or the
kinetics of mROS metabolism between hepatocytes
from young versus old WT mice (Fig. 3). On the other
hand, pre-treatment of hepatocytes with antimycin A
resulted in a striking and unexpected difference in the
mROS kinetics curves obtained from hepatocytes
isolated from young versus old WT mice (Fig. 4).
While the response of the hepatocytes from young
mice to antimycin A treatment was similar to that seen
in rotenone treated hepatocytes (i.e. an initial upward
tick and subsequent downward slope), hepatocytes
from old mice showed the opposite outcome. Addition
of PG in antimycin A pre-treated hepatocytes from old
mice resulted in a sudden decrease in the generation of
mROS that slowly and progressively returned towards
pretreatment levels as a function of time. We also



















































Fig. 2 Change in mROS production/metabolism over time. Data
from Fig. 1 was used to calculate differences in mROS intensities.
a Graph shows differences at t = 0 s (baseline). b t = 200 s (peak
after PG addition), and c t = 800 s (after recording began)
between young, middle age, and old WT hepatocytes and middle
age hepatocytes from Casp2-/- mice. Results from three
experiments are shown. Error bars = ± SEM























































Fig. 3 Hepatocytes from young and old WT mice show the
same mROS response following exposure to rotenone. Hepa-
tocytes were isolated from 5 and 28 month old WT mice by
perfusing their livers with a buffer solution containing EGTA,
followed by collagenase treatment. Dispersed hepatocytes were
seeded in glass bottom well chambers, treated with 20 lM of
rotenone for 30 min, and stained with MitoSOX. Cells were
then placed in a confocal microscope and the production of
mROS was monitored over time after the addition of a mixture
of pyruvate and glutamate. Recordings were performed over a
period of 13–15 min. The results from three independent
experiments are shown in a, b and c. Data was normalized for
basal intensity. Error bars = ± SEM
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pre-treated hepatocytes isolated from WT mice with a
mixture of both rotenone and antimycin A (Fig. 5).
After addition of PG, no initial response was seen in
either WT young or WT old. However, young WT
hepatocytes progressively developed mROS in an
upward linear fashion.
Taken together our results indicate that: (1) there is
a difference between the way hepatocytes from young
and old mice respond to dysfunction of the mitochon-
drial electron transport chain and subsequent produc-
tion and neutralization of mROS; (2) this difference is
most probably due to age dependent dysfunction of
complex III; and (3) absence of casp2 in hepatocytes
obtained from middle age mice respond in a similar
way as hepatocytes obtained from old WT mice in
terms of PG-induced mROS metabolism.
Discussion
Our previous studies have shown a progressive
increase in the activity of caspases that mediate
apoptosis induced through the mitochondrial pathway
as liver ages (Zhang et al. 2002). This suggests a strong
contribution of the intrinsic pathway of apoptosis to
liver aging. It is generally agreed that oxidative stress,
which is a potent inducer of apoptosis, increases with
age. The speculation that mitochondrial oxidative
stress may underlie age-associated increases in apop-
tosis in the liver is supported by the observation that
liver hepatocyte apoptosis is higher in old mice with


















































Fig. 4 Hepatocytes from young and old WT mice show a
marked difference in mROS response to antimycin A treatment
as a function of time when the electron transport chain is fed
with pyruvate and glutamate. Hepatocytes were isolated from 5
and 28 month old WT mice by perfusing their livers with a
buffer solution containing EGTA, followed by collagenase
treatment. Dispersed hepatocytes were seeded in glass bottom
well chambers, treated with 20 lM of antimycin A for 30 min,
and stained with MitoSOX. Cells were then placed in a confocal
microscope and the production of ROS from the mitochondria
was monitored over time after the addition of a mixture of
pyruvate and glutamate. Recordings were performed for
13–15 min. The results from three independent experiments
are shown in a, b and c. Data was normalized for basal intensity.
Error bars = ± SEM
















Fig. 5 Hepatocytes from young and old WT mice show a
marked difference in mROS response to a mixture of rotenone
plus antimycin A treatment as a function of time when the
electron transport chain is fed with pyruvate and glutamate.
Hepatocytes were isolated from 5 and 28 month old WT mice by
perfusing their livers with a buffer solution containing EGTA,
followed by collagenase treatment. Dispersed hepatocytes were
seeded in glass bottom well chambers, treated with a mixture of
20 lM of rotenone plus antimycin A for 30 min, and stained
with MitoSOX. Cells were then placed in a confocal microscope
and the production of ROS from the mitochondria was
monitored over time after the addition of a mixture of pyruvate
and glutamate. Recordings were performed for 13–15 min. The
results from three independent experiments are shown
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half the amount of MnSOD than in age-matched WT
mice (Kokoszka et al. 2001). These results validate
previous studies that showed increase numbers of
TUNEL positive hepatocytes in livers of aged Fisher
44 rats (Higami et al. 1997). In addition, we have also
shown that hepatocytes isolated from old rats are more
sensitive to oxidant-induced cell death than hepato-
cytes isolated from young rats (Zhang et al. 2002).
Casp2 has been implicated in apoptotic and non-
apoptotic processes such as cell cycle regulation,
tumor suppression and aging (Bouchier-Hayes and
Green 2012 for review). Casp2 has also been identified
as a central player in the mitochondrial pathway of
apoptosis (Guo et al. 2002; Boatright et al. 2003;
Enoksson 2004). Furthermore, casp2 has been
reported to be localized in the mitochondrial com-
partment (Susin et al. 1999, Deaciuc et al. 2004,
Cheung et al. 2006), although the localization of casp2
in mitochondria is still under debate (Mancini et al.
2000, O’Reilly et al. 2002, van Loo et al. 2002). Our
laboratory, as well as other groups, has suggested that
casp2 mediates apoptosis induced by the lipid perox-
idant tert-butyl hydroperoxide (tBOOH) (Amoroso
et al. 2002, Zhang et al. 2002). Mitochondria are a
major site of ROS generation and excess ROS triggers
apoptosis mediated by caspases. Consequently, the
role of casp2 as an initiator of mitochondrial apoptosis
is now commonly accepted.
To examine the potential role of casp2 in the
relationship between aging and mitochondrial oxida-
tive stress, we examined the implications of removal
of casp2 on hepatocyte mROS metabolism. These
studies have been performed in male mice for three
reasons: (1) All our previously published data on
casp2 deficient mice biology has been obtained using
male mice; and (2) hepatocytes used in these exper-
iments were cultured in vitro with specific media, thus
removing any potential impact of gender in the results.
Hepatocytes are cells with a high degree of metabolic
activity and are greatly enriched in mitochondria,
which in turn leads to production of high levels of
ROS. We examined ROS production from mitochon-
dria in hepatocytes isolated from young (5 months),
middle age (12 months) and old (25 months) WT
mice. Our data demonstrated that hepatocytes of old
mice do not produce as much initial mROS as
hepatocytes from young mice when mitochondrial
respiration is accelerated. In addition, the kinetics of
mROS neutralization were not as efficient in
hepatocytes isolated from old mice compared to that
observed in hepatocytes isolated from young mice.
These results indicate that older hepatocytes lack the
metabolic efficiency found in younger hepatocytes.
Inhibiting certain complexes of the electron trans-
port chain results in an increase in mROS production.
Thus, we examined the level of ROS production
following metabolic stimulation in the presence and
absence of inhibitors of the electron transport chain.
The two main sites responsible for ROS production
following inhibition are complex I and complex III.
We used rotenone and antimycin A to inhibit these
electron transport chain complexes, respectively. Our
results demonstrate that while there is no difference in
ROS generation between young and old hepatocytes
following complex I inhibition, hepatocytes from old
WT mice respond very differently to inhibition of
complex III in the mitochondrial electron transport
chain and subsequent generation and neutralization of
mROS than hepatocytes from young mice. However,
we did not detect any differences when complex I was
inhibited among hepatocytes of either age. These
results lead us to hypothesize that older hepatocytes
are less capable of handling the same or greater levels
of mROS produced during inhibition or dysfunction
mainly of complex III. Following treatment with both
rotenone and antimycin A, the initial rapid increase in
mROS production observed after metabolic stimula-
tion was completely inhibited. Subsequently, a steady
increase in mROS production was observed only in
young hepatocytes. These results suggest that first,
aging is associated with differences in mROS metab-
olism and second, that aging affects complex III
activity preferentially with respect to mitochondrial
oxidative stress. We also show that hepatocytes from
middle age Casp2-/- mice display a greater difficulty
in neutralizing mROS than hepatocytes from their age-
matched WT counterparts, and in fact resemble the
characteristics of mROS neutralization found in
hepatocytes obtained from old WT mice. These data
implicate casp2 in the preferential metabolism of
mROS generated from complex III. Recent evidence
suggests that when complex III is inhibited, complex II
may be a source of ROS (Quinlan et al. 2012). We
examined mROS production in young and old WT
hepatocytes containing non-functional complex I and
III (Fig. 5). Our results indicate that complex II is not a
source of ROS and it is in agreement with previous
findings (Chen et al. 2003), using glutamate, but not
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succinate as a substrate. Since the equivalency of
mROS metabolism in middle aged Casp2-/- mice is
comparable to old WT mice, our data suggests that
casp2 is an important player in the aging process
resulting from oxidative stress.
At the present time, the mechanisms by which
casp2 may sense and respond to complex III generated
ROS or its targets are unknown and are the focus of
ongoing studies. However, recent findings suggest a
number of feasible mechanisms by which casp2 may
regulate cellular ROS levels and responses. Higher
levels of ROS can damage enzymes responsible for
production of NADPH and Calmodulin dependent
kinase II (CaMK II) (Erickson et al. 2008). In addition,
scavenging ROS or repairing oxidized macromole-
cules consume NADPH. These changes can poten-
tially impair the function of CaMK II. Because CaMK
II phosphorylates the cysteine apoptotic protease,
procaspase-2, at Ser135 and inhibits its activation
(Nutt et al. 2005), it is possible that partial loss of
CaMK II function reduces the threshold of oxidative
stress required for the activation of casp2, resulting in
apoptosis. NADPH, a co-factor of several anti-oxidant
enzymes such as glutathione reductase and thiore-
doxin reductase, enhances CaMK II-mediated inhibi-
tion of casp2 (Lee et al. 2001). Because NADPH is a
critical molecule in redox regulation, casp2 activity
may be ultimately regulated by cellular redox. Indeed,
casp2 is necessary for mitochondrial oxidative stress-
induced apoptosis because its absence protects cells
treated with mitochondrial complex I inhibitors such
as rotenone from apoptosis (Lopez-Cruzan et al. 2005,
Tiwari et al. 2011). In addition, we find casp2 activity
to be increased prior to other caspases in MnSOD-
partially-deficient mice that have enhanced mitochon-
drial oxidant stress (data not shown). Because it is the
most conserved caspases (shares [90 % homology
with human casp2), we aligned the protein sequence of
casp2 from several species and found that casp2
contains 17 cysteine residues conserved across. Thus,
casp2 is the highest cysteine containing caspase out of
all the known caspases. Cysteine residues are known
to regulate protein function via oxidation and reduc-
tion of disulfide bonds as a function of the redox
environment. One of these 17 cysteine residues is
involved in the dimerization of casp2 monomers via
formation of a disulfide bond that stabilizes the
molecule (Schweizer et al. 2003), but is apparently
not required for casp2 activation. Four of the
remaining 16 cysteines are aligned in the dimer in a
conformation accessible to sense the redox environ-
ment, but do not form disulfide bridges under phys-
iological conditions. We hypothesize that one or more
of these 4 cysteines might serve as sensors of
mitochondrial oxidative stress, potentially via
oxidation.
In earlier studies published by us employing a
unique combination of spatially resolved single-cell
chemical kinetics, scaling analysis, and biochemical
assays, we observed that young liver cells manifest
nonlinear dynamics for efficiently regulating ROS
generation/removal machinery, and that these regula-
tory correlations in free radical dynamics are dimin-
ished in aged cells, suggesting that the aging process
modulates chemical dynamics (complexity) in liver
cell energy metabolism (Ramanujan and Herman
2007). We speculated that these differences arise from
nonlinear network interactions among glycolysis,
gluconeogenesis, and mitochondrial electron transport
chain. Pyruvate dehydrogenase is the key enzyme that
converts glycolytic product pyruvate to acetyl-CoA as
an input to mitochondrial pathway, and it is known
that pyruvate dehydrogenase is inhibited by excess
NADH/acetyl-CoA (product inhibition). If the mito-
chondrial pathway is defective in aged cells, unme-
tabolized pyruvate will be converted back to glucose
by gluconeogenesis, which then will initiate the
glycolytic pathway. It has been reported earlier that
aging is associated with ROS-induced chronic dys-
function of mitochondrial respiratory chain, either at
site I or III, and that mitochondria isolated from aged
animals show reduced sensitivity to complex I inhib-
itor (Fosslien 2001). Similar trends were observed in
these studies, suggesting that aging in liver is accom-
panied by a dysfunctional mitochondrial network that
can be due to structural or functional respiratory
defects, or both. These findings are consistent with the
data reported here, that defects in complex III
accompany the aging process and loss of casp2.
Lastly, a recent publication (Shalini et al. 2012), that
repeats and recapitulates our previous finding in bone,
livers, mouse embryonic fibroblasts and hepatocytes
from Casp2-/- mice (Lopez-Cruzan et al. 2005, Zhang
et al. 2007, Tiwari et al. 2011) showed that old
Casp2-/- mice have increased cellular levels of
oxidized proteins, lipid peroxides and DNA damage.
Fibroblasts and neurons from Casp2 null mice generate
higher levels of endogenous ROS that is associated
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with decreased levels of antioxidant enzymes (Tiwari
et al. 2011). Casp2 was found to upregulate anti-
oxidant protein expression by activating the transcrip-
tion factor FoxO family (Shalini et al. 2012). In
particular, FoxO3 is responsible for expression of
catalase, MnSOD, and sestrins genes; the later which
activates the peroxiredoxin family of H2O2 detoxifiers.
In the absence of casp2, these antioxidants are
decreased, and in the case of MnSOD, it might explain
the increased mROS production seen in older WT and
middle age casp2 null hepatocytes. Taken together,
these observations demonstrate strong mechanistic
links between casp2, oxidative stress and aging.
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